Cognitive Behavioural Therapy for Anxiety
Conditions of Use
Copyright of the module remains with the authors, but in line with the sponsor's policy, the module can be used free of charge under the following conditions:
- The module may not be commercialized in any way.
- In any publications, the authors will refer to the original publication of the CBT module (1).
- Any translations not yet available on this website, will be send to the authors for publication on this website.
- Copyright of any translations will remain with the authors of the original CBT module.
Translations
Please find all available translations below.
| Manual for Professionals | Patient Workbook |
|---|---|
| English (US) | English (US) |
| Dutch | Dutch |
References
- Mulders AEP, Moonen AJH, Dujardin K, Kuijf ML, Duits AA, Flinois B, Handels RLH Lopes R, Leentjens AFG. Cognitive behavioural therapy for anxiety disorders in Parkinson’s disease: design of a randomised controlled trial to assess clinical effectiveness and changes in cerebral connectivity. J Psychosom Res. 2018;112:32-39. doi: 10.1016/j.jpsychores.2018.04.002.
- Moonen AJH, Mulders AEP, Defebvre L, Duits AA, Flinois B, Köhler S, Kuijf ML, Leterme AC, Servant D, de Vugt M, Dujardin K, Leentjens AFG. Cognitive behavioral therapy for anxiety in Parkinson’s disease: a randomized controlled trial. Mov Disord 2021 (accepted). doi: 10.1002/mds.28533.
- Carey G, Lopes R, Moonen AJH, Mulders AEP, De Jong JAJ, Kuchcinski G, Defebvre L, Kuijf ML, Dujardin K. Leentjens AFG. Changes in brain functional connectivity after cognitive behavioural therapy for anxiety in Parkinson’s disease: a longitudinal MRI study (submitted).